TYPE2 DIABETES MELLITUS
Clinical trials for TYPE2 DIABETES MELLITUS explained in plain language.
Never miss a new study
Get alerted when new TYPE2 DIABETES MELLITUS trials appear
Sign up with your email to follow new studies for TYPE2 DIABETES MELLITUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Daily pill aims to tackle weight and diabetes together
Disease control Not yet recruitingThis phase 3 study tests aleniglipron, an oral medication taken once daily, for helping adults with obesity or overweight and type 2 diabetes manage their weight over the long term. Participants receive either aleniglipron or a placebo for 76 weeks. The main goal is to see how mu…
Matched conditions: TYPE2 DIABETES MELLITUS
Phase: PHASE3 • Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New program aims to help immigrants better manage diabetes
Disease control Not yet recruitingThis study tests a program that combines online diabetes education videos with help connecting to social services for low-income Chinese and Latino/a immigrants with type 2 diabetes. The goal is to improve blood sugar control and see if people find the program useful and easy to …
Matched conditions: TYPE2 DIABETES MELLITUS
Phase: NA • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Your diet may slow kidney disease: new study investigates
Knowledge-focused Not yet recruitingThis study looks at how eating habits relate to the progression of chronic kidney disease in 160 adults with type 2 diabetes. Researchers will track changes in kidney function over 6 months. The goal is to find dietary patterns that might help protect the kidneys.
Matched conditions: TYPE2 DIABETES MELLITUS
Sponsor: Mariam Emeel Haleem Naseem • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:03 UTC